Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans. Part A: use of FDA post-market reports to create a database of hepatobiliary and urinary tract toxicities (Q83783482)
Jump to navigation
Jump to search
scientific article published on 01 June 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans. Part A: use of FDA post-market reports to create a database of hepatobiliary and urinary tract toxicities |
scientific article published on 01 June 2009 |
Statements
Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans. Part A: use of FDA post-market reports to create a database of hepatobiliary and urinary tract toxicities (English)
Carling J Ursem
Naomi L Kruhlak
Joseph F Contrera
Philip M MacLaughlin
R Daniel Benz
Edwin J Matthews
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference